Shareholders approve increase to equity plan shares by 5M at Wave Life Sciences AGM

Wave Life Sciences Ltd.

Shareholders approved amendment to 2021 Equity Incentive Plan, increasing share authorization by 5,000,000 shares.
Proposal passed with 82,321,912 for, 12,184,069 against, 32,017 abstain.
Nine directors re-elected; Christian Henry received 80,627,620 for, 13,894,737 against.
KPMG LLP re-appointed as auditor with 101,761,729 for, 316,576 against.
Say-on-pay advisory vote passed with 94,163,361 for, 356,573 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.